Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

The latest news from Arcinova

April 26, 2019

Accelerating the path to first-in-human clinical trials

Our Head of Drug Substance, Paul Quigley, was recently interviewed by Outsourcing Pharma to coincide with his presentation at CPhI North America 2019. He explained the importance of ensuring rapid
April 17, 2019

Article: Chemistry 4.0 in pharmaceutical development

"The pharmaceutical industry is being revolutionised by the utilisation of digital technologies. Chemistry 4.0 describes this digital transformation and how its delivery is paving the way for the
April 16, 2019

Crédit d'impôt recherche Grants Arcinova with R&D Status

Arcinova has been recognised and approved by the Crédit d'impôt recherche (CIR) as an organisation undertaking R&D activities.  This will bestow significant benefits upon any French cus
March 18, 2019

Investigating multi-dimensional problems in drug substance

"Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise." Our CSO, Gareth
February 18, 2019

Panel discussion on Pharma and Chemical Supply Chain

Our CSO, Gareth Jenkins, took part in a panel discussion on the pharmaceutical supply chain. He offered his insights on the key issues and trends shaping the industry and the fac
February 5, 2019

Arcinova's Chief Scientific Consultant Wins 2019 Scholar Award

  Dr. Aggarwal is currently working as a Chemistry Professor at the University of Bristol however, Dr. Aggarwal also works with Arcinova in January 2018 as our Chief Scientific Consul
February 1, 2019

Article: Continuous transformation of pharmaceutical manufacturing

"Continuous flow technology is particularly suitable for fast, challenging chemistries that are difficult to control." This article explores the benefits of continuous flow chemistry in sy
December 11, 2018

Arcinova awarded £1 million government grant

  Arcinova, a multi-service Contract Research and Development Organisation (CRDO), has been awarded a £1 million government grant for its £2 million Fill-Inova Project. The award wi
September 30, 2018

Gareth Jenkins, CSO at Arcinova, is newly appointed to the EPSRC

Gareth Jenkins, CSO at Arcinova, has been recently appointed to join the Strategic Advisory Network (SAN) with another 11 members. Formed in 1994, the Engineering and Physical S




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH